PATH vs VREX
Uipath Inc (PATH) versus Varex Imaging Corp (VREX) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Varex Imaging Corp (VREX) is a medical devices company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VREX revenue for 2025-10-03 was $844.6M. Net income was -$69.9M. Revenue was up 4.1% from 2024-09-27 to 2025-10-03. VREX currently screens at market cap $350.0M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VREX currently screens at market cap $350.0M.
Not investment advice. Open the PATH and VREX stock pages for the full models.
Not investment advice.